In the latest session, Atossa Therapeutics Inc (NASDAQ: ATOS) closed at $1.80 down -4.76% from its previous closing price of $1.89. In other words, the price has decreased by -$0.0900 from its previous closing price. On the day, 3783534 shares were traded.
Ratios:
For a deeper understanding of Atossa Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 28.35 and its Current Ratio is at 28.35. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Maxim Group on January 26, 2018, initiated with a Buy rating and assigned the stock a target price of $2.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Nov 15 ’23 when WEAVER GREGORY L sold 50,000 shares for $0.65 per share. The transaction valued at 32,500 led to the insider holds 55 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ATOS now has a Market Capitalization of 225.55M and an Enterprise Value of 131.52M.
Stock Price History:
The Beta on a monthly basis for ATOS is 1.17, which has changed by 160.87% over the last 52 weeks, in comparison to a change of 29.19% over the same period for the S&P500. Over the past 52 weeks, ATOS has reached a high of $1.89, while it has fallen to a 52-week low of $0.59. The 50-Day Moving Average of the stock is 1.0680, while the 200-Day Moving Average is calculated to be 0.9127.
Shares Statistics:
For the past three months, ATOS has traded an average of 914.39K shares per day and 2.73M over the past ten days. A total of 126.62M shares are outstanding, with a floating share count of 125.28M. Insiders hold about 0.02% of the company’s shares, while institutions hold 19.14% stake in the company. Shares short for ATOS as of Feb 29, 2024 were 7.15M with a Short Ratio of 7.82, compared to 6.84M on Jan 31, 2024. Therefore, it implies a Short% of Shares Outstanding of 5.71% and a Short% of Float of 5.71%.
Earnings Estimates
There are 3 different market analysts currently analyzing its stock. On average, analysts expect EPS of -$0.06 for the current quarter, with a high estimate of -$0.05 and a low estimate of -$0.06, while EPS last year was -$0.06. The consensus estimate for the next quarter is -$0.06, with high estimates of -$0.06 and low estimates of -$0.06.
Analysts are recommending an EPS of between -$0.23 and -$0.24 for the fiscal current year, implying an average EPS of -$0.24. EPS for the following year is -$0.26, with 3 analysts recommending between -$0.25 and -$0.26.
